MDXG Q3 2020 Earnings — MiMedx Group, Inc. Revenue & Financial Results | Market Cap Arena

MDXGMiMedx Group, Inc.

$666M

Q3 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$64M-27.6% YoY

Gross Profit

$54M84.0% margin

Operating Income

-$10M-15.1% margin

Net Income

-$19M-30.2% margin

EPS (Diluted)

$-0.18

QoQ Revenue Growth

+19.9%

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$5M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$213M

Total Liabilities

$109M

Stockholders' Equity

$104M

Cash & Equivalents

$110M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$64M	$89M	-27.6%
Gross Profit	$54M	$76M	-28.6%
Operating Income	-$10M	$14M	-168.4%
Net Income	-$19M	$12M	-256.9%